DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Delcath Systems, Inc. (NASDAQ: DCTH)



company name or ticker

Worst Performing Industries For June 2, 2015

Delcath Systems (DCTH) Weak On High Volume

Health Care Sector Update for 05/29/2015: DCTH,KBIO,SVON,XXII

Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015

Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Ye

Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Years

ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open F

ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment

Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic

Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma

3 Basic Checks To Value Cheap Net Net Stocks

Delcath Adds New U.S. Center To Global Phase 2 Hepatocellular Carcinoma Program

Delcath to Offer Data Highlighting Melphalan/HDS Trial at SSO Annual Meeting

See More Articles...